BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9016638)

  • 1. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
    Si Z; Amendt BA; Stoltzfus CM
    Nucleic Acids Res; 1997 Feb; 25(4):861-7. PubMed ID: 9016638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Madsen JM; Stoltzfus CM
    Retrovirology; 2006 Feb; 3():10. PubMed ID: 16457729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
    Si ZH; Rauch D; Stoltzfus CM
    Mol Cell Biol; 1998 Sep; 18(9):5404-13. PubMed ID: 9710624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
    J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of replication-competent revertants of a Rous sarcoma virus src gene oversplicing mutant.
    Zhang L; Simpson SB; Stoltzfus CM
    J Virol; 1996 Jun; 70(6):3636-44. PubMed ID: 8648698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    Bilodeau PS; Domsic JK; Stoltzfus CM
    J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
    Madsen JM; Stoltzfus CM
    J Virol; 2005 Aug; 79(16):10478-86. PubMed ID: 16051840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Staffa A; Cochrane A
    Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication.
    Erkelenz S; Hillebrand F; Widera M; Theiss S; Fayyaz A; Degrandi D; Pfeffer K; Schaal H
    Retrovirology; 2015 Mar; 12():29. PubMed ID: 25889056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
    Bilodeau PS; Domsic JK; Mayeda A; Krainer AR; Stoltzfus CM
    J Virol; 2001 Sep; 75(18):8487-97. PubMed ID: 11507194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
    Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
    J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
    Staffa A; Cochrane A
    J Virol; 1994 May; 68(5):3071-9. PubMed ID: 7512159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
    Caputi M; Mayeda A; Krainer AR; Zahler AM
    EMBO J; 1999 Jul; 18(14):4060-7. PubMed ID: 10406810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
    Exline CM; Feng Z; Stoltzfus CM
    J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    Tange TØ; Kjems J
    J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A suboptimal src 3' splice site is necessary for efficient replication of Rous sarcoma virus.
    Zhang L; Stoltzfus CM
    Virology; 1995 Feb; 206(2):1099-107. PubMed ID: 7856084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.
    Zheng ZM; He PJ; Baker CC
    J Virol; 1999 Jan; 73(1):29-36. PubMed ID: 9847303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.